申请人:Southern Research Institute
公开号:EP2332551A1
公开(公告)日:2011-06-15
Patients suffering from cancer are treated by being administered a compound represented by formula: (1), wherein each R individually is H or an aliphatic or aromatic acyl group; A is selected from the group consisting of formulae (IIa, IIb, IIc, IId), wherein X is selected from the group consisting of hydrogen, fluorine, alkoxy, alkyl, haloalkyl, alkenyl, haloalkenyl, alkynyl, amino, monoalkylamino, dialkylamino, cyano and nitro. The above compounds also inhibit DNA replication in mammalian cells.
癌症患者可通过服用由式表示的化合物进行治疗:(1),其中每个 R 单独为 H 或脂肪族或芳香族酰基;A 选自由式(IIa、IIb、IIc、IId)组成的组,其中 X 选自由氢、氟、烷氧基、烷基、卤代烷基、烯基、卤代烯基、炔基、氨基、单烷基氨基、二烷基氨基、氰基和硝基组成的组。上述化合物还能抑制哺乳动物细胞中 DNA 的复制。